The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities
K Mima, T Hamada, K Inamura, H Baba, T Ugai… - Gut …, 2023 - Taylor & Francis
Accumulating evidence indicates an alarming increase in the incidence of early-onset
cancers, which are diagnosed among adults under 50 years of age, in the colorectum …
cancers, which are diagnosed among adults under 50 years of age, in the colorectum …
[HTML][HTML] An overview of extrahepatic cholangiocarcinoma: from here to where?
Y Yang, X Zhang - Frontiers in Oncology, 2023 - frontiersin.org
Extrahepatic cholangiocarcinoma (eCCA) contains perihilar cholangiocarcinoma and distal
cholangiocarcinoma both of which can arise at any point of the biliary tree and originate from …
cholangiocarcinoma both of which can arise at any point of the biliary tree and originate from …
[HTML][HTML] Epidemiology of cholangiocarcinoma
M Qurashi, M Vithayathil, SA Khan - European Journal of Surgical Oncology, 2023 - Elsevier
Cholangiocarcinoma (CCA) represents a heterogenous set of malignancies arising from the
biliary tract. Classification of CCA subdivides tumours into intrahepatic (iCCA) and …
biliary tract. Classification of CCA subdivides tumours into intrahepatic (iCCA) and …
[HTML][HTML] Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine
MA Polidoro, E Ferrari, C Soldani, B Franceschini… - JHEP Reports, 2024 - Elsevier
Background & Aims Cholangiocarcinoma (CCA) is a primary liver tumour characterised by a
poor prognosis and limited therapeutic options. Available 3D human CCA models fail to …
poor prognosis and limited therapeutic options. Available 3D human CCA models fail to …
[HTML][HTML] Natural flavonoids quercetin and kaempferol targeting G2/M cell cycle-related genes and synergize with smac mimetic LCL-161 to induce necroptosis in …
T Lomphithak, P Jaikla, A Sae-Fung, S Sonkaew… - Nutrients, 2023 - mdpi.com
Cholangiocarcinoma (CCA) is an aggressive cancer associated with a very poor prognosis
and low survival rates, primarily due to late-stage diagnosis and low response rates to …
and low survival rates, primarily due to late-stage diagnosis and low response rates to …
Exploration of a screening model for intrahepatic cholangiocarcinoma patients prone to cuproptosis and mechanisms of the susceptibility of CD274-knockdown …
Z Shen, J Cai, L Tao, J Zheng, Z Ye, Y Liu, H Pan… - Cancer Gene …, 2023 - nature.com
Intrahepatic cholangiocarcinoma (ICC) is a form of liver cancer with poor long-term survival
rates that requires novel therapeutic methods. Our team's previous research found that ICC …
rates that requires novel therapeutic methods. Our team's previous research found that ICC …
[HTML][HTML] Characterization of the distinct immune microenvironments between hepatocellular carcinoma and intrahepatic cholangiocarcinoma
S Jiang, H Lu, Y Pan, A Yang, A Aikemu, H Li, R Hao… - Cancer Letters, 2024 - Elsevier
As two major types of primary liver cancers, the tumor immune microenvironment (TIME) of
hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) have been well …
hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) have been well …
[HTML][HTML] Cholangiocarcinoma in the Era of Immunotherapy
E Manthopoulou, D Ramai, J Dhar, J Samanta… - Vaccines, 2023 - mdpi.com
Cholangiocarcinoma (CCA) is a rare malignancy of the gastrointestinal tract, with aggressive
behavior, and portends a poor prognosis. Traditionally, it is classified according to its site of …
behavior, and portends a poor prognosis. Traditionally, it is classified according to its site of …
[HTML][HTML] Intercellular crosstalk between cancer cells and cancer-associated fibroblasts via exosomes in gastrointestinal tumors
L Cao, H Ouyang - Frontiers in Oncology, 2024 - frontiersin.org
Gastrointestinal (GI) tumors are a significant global health threat, with high rates of morbidity
and mortality. Exosomes contain various biologically active molecules like nucleic acids …
and mortality. Exosomes contain various biologically active molecules like nucleic acids …
Alcohol-associated liver cancer
Heavy alcohol intake induces a wide spectrum of liver diseases ranging from steatosis,
steatohepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Although alcohol …
steatohepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Although alcohol …